首页 | 本学科首页   官方微博 | 高级检索  
     

消眩止晕片治疗颈性眩晕痰瘀内阻证的临床观察
引用本文:董成林,丁晶,王晶,丁玉峰. 消眩止晕片治疗颈性眩晕痰瘀内阻证的临床观察[J]. 中国实验方剂学杂志, 2019, 25(6): 108-113
作者姓名:董成林  丁晶  王晶  丁玉峰
作者单位:华中科技大学 同济医学院 附属同济医院, 武汉 430030,华中科技大学 同济医学院 附属同济医院, 武汉 430030,华中科技大学 同济医学院 附属同济医院, 武汉 430030,华中科技大学 同济医学院 附属同济医院, 武汉 430030
基金项目:湖北省自然科学基金项目(2013CFB162)
摘    要:
目的:探讨消眩止晕片治疗颈性眩晕痰瘀内阻证的疗效及对氧化应激和血清内皮素(ET)-1,5-羟色胺(5-HT)和一氧化氮(NO)水平的影响。方法:筛选符合要求就诊的颈性眩晕患者118例为研究对象,参照数字表法随机分为对照组和治疗组各59例。对照组采用正骨联合针刺治疗。治疗组在对照组治疗的基础上口服消眩止晕片,5片/次,3次/d。两组患者均进行3周的连续治疗。比较两组患者颈性眩晕症状与功能评估量表(ESCV)评分、眩晕障碍量表(DHI)评分、椎-基底动脉血流速度、生活质量及临床疗效。检测两组患者血清超氧化物歧化酶(SOD),丙二醛(MDA),ET-1,5-HT和NO水平。结果:治疗后,治疗组ESCV评分显著高于对照组,DHI评分明显低于对照组(P 0. 01)。治疗组治疗后患者左椎动脉、右椎动脉及基底动脉血流速度均显著高于对照组(P 0. 01)。治疗组患者的临床总有效率为98. 25%,高于对照组的83. 93%(P 0. 05)。治疗后,治疗组患者SF-36量表各项评分均显著高于对照组(P 0. 01)。治疗后,治疗组患者血清SOD,NO水平均显著高于对照组,MDA,ET-1和5-HT水平均明显低于对照组(P 0. 01)。结论:在正骨联合针刺治疗的基础上,加服消眩止晕片治疗颈性眩晕疗效显著,调节患者体内氧化应激及血清ET-1,5-HT和NO水平可能与其临床疗效有关。

关 键 词:消眩止晕片  颈性眩晕  痰瘀内阻证  氧化应激
收稿时间:2018-08-06

Clinical Efficacy of Xiaoxuan Zhiyun Tablet in Treating Cervical Vertigo with Syndrome of Phlegm and Blood Stasis Resistance
DONG Cheng-lin,DING Jing,WANG Jing and DING Yu-feng. Clinical Efficacy of Xiaoxuan Zhiyun Tablet in Treating Cervical Vertigo with Syndrome of Phlegm and Blood Stasis Resistance[J]. China Journal of Experimental Traditional Medical Formulae, 2019, 25(6): 108-113
Authors:DONG Cheng-lin  DING Jing  WANG Jing  DING Yu-feng
Affiliation:Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China,Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China,Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China and Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Abstract:
Objective:To observe the efficacy of Xiaoxuan Zhiyun tablet in treating cervical vertigo with syndrome of phlegm and blood stasis resistance and its effect on oxidative stress and serum levels of endothelin-1(ET-1), 5-hydroxytryptamine (5-HT), and nitric oxide (NO). Method:One hundred eighteen cervical vertigo cases were selected and randomly divided into control group (59 cases) and treatment group (59 cases) by random number table. Control group was given bone setting combined with acupuncture. In addition to the therapy of control group, treatment group was given Xiaoxuan Zhiyun tablet (1 dose/day, tid). Both groups were treated for 3 weeks. Scores of cervical vertigo symptom and function assessment scale (ESCV) and vertigo disorder scale (DHI), blood velocity of vertebrobasilar artery, life quality and efficacy were compared between both groups. Serum levels of superoxide dismutase (SOD), malondialdehyde (MDA), ET-1, 5-HT and NO were detected in both groups. Result:After treatment, ESCV score of treatment group was obviously higher, while DHI score was lower than control group (P<0.01). Blood flow velocity of left vertebral artery, right vertebral artery and basilar artery in treatment group were obviously higher than those of control group after treatment (P<0.01). Total clinical efficacy of treatment group wsa 98.25%, which was superior to 83.93% of control group (P<0.05). After treatment, SF-36 index score was remarkably higher than that of control group (P<0.01). Serum levels of SOD and NO of treatment group were higher, while MDA, ET-1,5-HT were lower than control group (P<0.01). Conclusion:In addition to the routine therapy, the efficacy of Xiaoxuan Zhiyun tablet in treating cervical vertigo is significant, which may be related with regulation of oxidative stress and serum levels of ET-1, 5-HT and NO.
Keywords:Xiaoxuan Zhiyun tablet  cervical vertigo  syndrome of phlegm and blood stasis resistance  oxidative stress
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号